BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20692127)

  • 1. Update on brucellosis: therapeutic challenges.
    Solera J
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S18-20. PubMed ID: 20692127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of human brucellosis.
    Solera J
    J Med Liban; 2000; 48(4):255-63. PubMed ID: 11214198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and optimum treatment of brucellosis.
    Solera J; Martínez-Alfaro E; Espinosa A
    Drugs; 1997 Feb; 53(2):245-56. PubMed ID: 9028744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
    Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
    Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for human brucellosis.
    Al-Tawfiq JA
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):109-20. PubMed ID: 18251668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter therapeutic study of 1100 children with brucellosis.
    Lubani MM; Dudin KI; Sharda DC; Ndhar DS; Araj GF; Hafez HA; al-Saleh QA; Helin I; Salhi MM
    Pediatr Infect Dis J; 1989 Feb; 8(2):75-8. PubMed ID: 2649867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial.
    Roushan MR; Amiri MJ; Janmohammadi N; Hadad MS; Javanian M; Baiani M; Bijani A
    J Antimicrob Chemother; 2010 May; 65(5):1028-35. PubMed ID: 20215128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches to the antibiotic treatment of brucellosis.
    Pappas G; Solera J; Akritidis N; Tsianos E
    Int J Antimicrob Agents; 2005 Aug; 26(2):101-5. PubMed ID: 16039098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
    Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
    Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucellosis in children of Dhofar Region, Oman.
    El-Amin EO; George L; Kutty NK; Sharma PP; Choithramani RS; Jhaveri VP; Salil P; Bedair SM
    Saudi Med J; 2001 Jul; 22(7):610-5. PubMed ID: 11479644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human brucellosis in Kuwait: a prospective study of 400 cases.
    Lulu AR; Araj GF; Khateeb MI; Mustafa MY; Yusuf AR; Fenech FF
    Q J Med; 1988 Jan; 66(249):39-54. PubMed ID: 3051080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three different combination therapies in the treatment of human brucellosis.
    Ersoy Y; Sonmez E; Tevfik MR; But AD
    Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline-rifampicin: physicians' inferior choice in brucellosis or how convenience reigns over science.
    Pappas G; Siozopoulou V; Akritidis N; Falagas ME
    J Infect; 2007 May; 54(5):459-62. PubMed ID: 17070921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic treatment of brucellosis].
    Bertrand A
    Presse Med; 1994 Jun; 23(24):1128-31. PubMed ID: 7971834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on treatment options for spinal brucellosis.
    Ulu-Kilic A; Karakas A; Erdem H; Turker T; Inal AS; Ak O; Turan H; Kazak E; Inan A; Duygu F; Demiraslan H; Kader C; Sener A; Dayan S; Deveci O; Tekin R; Saltoglu N; Aydın M; Horasan ES; Gul HC; Ceylan B; Kadanalı A; Karabay O; Karagoz G; Kayabas U; Turhan V; Engin D; Gulsun S; Elaldı N; Alabay S
    Clin Microbiol Infect; 2014 Feb; 20(2):O75-82. PubMed ID: 24118178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood brucellosis: a study of 102 cases.
    al-Eissa YA; Kambal AM; al-Nasser MN; al-Habib SA; al-Fawaz IM; al-Zamil FA
    Pediatr Infect Dis J; 1990 Feb; 9(2):74-9. PubMed ID: 2314956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early clinical response to different therapeutic regimens for human brucellosis.
    Malik GM
    Am J Trop Med Hyg; 1998 Feb; 58(2):190-1. PubMed ID: 9502602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen.
    Pappas G; Seitaridis S; Akritidis N; Tsianos E
    Int J Antimicrob Agents; 2004 Nov; 24(5):502-7. PubMed ID: 15519485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility and treatment of brucellosis.
    Al-Tawfiq JA; Memish ZA
    Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):51-4. PubMed ID: 22812615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brucellosis: clinical presentation, diagnosis, complications and therapeutic options].
    Sakran W; Chazan B; Koren A
    Harefuah; 2006 Nov; 145(11):836-40, 860. PubMed ID: 17183958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.